Activation-induced cell death in B lymphocytes-Reference-Cited by-同舟云学术

Activation-induced cell death in B lymphocytes

Published:2000-09 Issue:3 Volume:10 Page:179-192
ISSN:1001-0602
Container-title:Cell Research
language:en
Short-container-title:Cell Res

Author:

DONJERKOVIć Dubravka,SCOTT David W

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology

Link

http://www.nature.com/articles/7290047.pdf

Reference77 articles.

1. Monroe JG . Tolerance sensitivity of immature-stage B cells: can developmentally regulated B cell antigen receptor (BCR) signal transduction play a role? J Immunol 1996; 156:2657–60.

2. Pennell CA, Scott DW . Lymphoma models for B cell activation and tolerance. IV. Growth inhibition by anti-Ig of CH31 and CH33 B lymphoma cells. Eur J Immunol 1986; 16:1577–81.

3. Scott DW, Livnat D, Pennell CA et al. Lymphoma models for B cell activation and tolerance. III. Cell cycle dependence for negative signalling of WEHI-231 B lymphoma cells by anti-mu. J Exp Med 1986; 164:156–64.

4. Benhamou LE, Cazenave PA, Sarthou P . Anti- immunoglobulins induce death by apoptosis in WEHI- 231 B lymphoma cells. Eur J Immunol 1990; 20:1405–7.

5. Hasbold J, Klaus GG . Anti-immunoglobulin antibodies induce apoptosis in immature B cell lymphomas. Eur J Immunol 1990; 20:1685–90.

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disruption of KLHL6 Fuels Oncogenic Antigen Receptor Signaling in B-Cell Lymphoma;Blood Cancer Discovery;2024-04-17

2. Obinutuzumab‐Based Drug‐Free Macromolecular Therapeutics Synergizes with Topoisomerase Inhibitors;Macromolecular Bioscience;2023-10-27

3. Engineering B cells with customized therapeutic responses using a synthetic circuit;Molecular Therapy - Nucleic Acids;2023-09

4. At low levels, inorganic mercury interference with antigen signaling is associated with modifications to a panel of novel phosphoserine sites in B cell receptor pathway proteins;Toxicology in Vitro;2023-06

5. Multi-targeted immunotherapeutics to treat B cell malignancies;Journal of Controlled Release;2023-06